Nutralife Biosciences Inc (NLBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 0 | 17 | 22 | 28 | 9 |
| Receivables | 0 | 0 | 33 | 51 | 1 |
| Inventories | 0 | 97 | 112 | 90 | 70 |
| TOTAL | $0 | $385 | $1,996 | $170 | $79 |
| Non-Current Assets | |||||
| PPE Net | 0 | 238 | 241 | 249 | 237 |
| TOTAL | $0 | $238 | $241 | $249 | $237 |
| Total Assets | $0 | $623 | $2,237 | $419 | $316 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 1,111 | 1,001 | 790 | 982 |
| Accounts payable and accrued liabilities | 0 | 33 | 41 | 25 | 26 |
| Accrued Expenses | 0 | 470 | 351 | 308 | 274 |
| Other current liabilities | 0 | 35 | 383 | 275 | 25 |
| TOTAL | $0 | $2,157 | $2,294 | $1,865 | $1,650 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 63 | 229 | 1 |
| TOTAL | $0 | $N/A | $63 | $229 | $1 |
| Total Liabilities | $0 | $2,157 | $2,358 | $2,094 | $1,651 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | 3,107 | 22,917 | 22,917 | 22,392 |
| Common Shares | 0 | 3 | 2 | 2 | 2 |
| Retained earnings | 0 | -7,031 | -6,640 | -5,860 | -5,359 |
| TOTAL | $0 | $-1,533 | $-121 | $-1,675 | $-1,335 |
| Total Liabilities And Equity | $0 | $623 | $2,237 | $419 | $316 |